Editorial Office
Editor-in-Chief
Prof. Dr. Ulrich Certa
Department of Molecular Toxicology, F. Hoffmann-La Roche AG, 4070 Basel, Switzerland
Tel. +41 61 688 53 40
E-Mail: ulrich.certa@roche.com
Interests: pharmacogenomics; drug safety; transcriptional responses to drugs; copy-number variation; deep sequencing; genomic analysis of animal models
Managing Editor
Ms. Grace Lu
MDPI Tongzhou Office, Suites 307-308, Liyuanbeijie Road, 186, Liyuan, Tongzhou, Beijing 101101, China
Tel. +86 10 5901 1009; Fax: +86 10 5901 1089
E-Mail: grace.lu@mdpi.com
Production Editor
Dr. Brietta Pike
MDPI AG, Postfach, CH-4005 Basel, Switzerland. Office: Kandererstrasse 25, 4057 Basel
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18
E-Mail: pike@mdpi.com
Publisher
Dr. Shu-Kun Lin
MDPI AG, Postfach, CH-4005 Basel, Switzerland. Office: Kandererstrasse 25, 4057 Basel
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18
Website: http://www.mdpi.org/lin/
E-Mail: lin@mdpi.com
Editorial Board
Prof. Dr. Jürg Bähler
Department of Genetics, Evolution & Environment and UCL Cancer Institute, University College London, Darwin Building, Gower Street, London, WC1E 6BT, UK
Tel. +44 2031 081602; Fax: +44 2076 797096
Website: http://www.bahlerlab.info
E-Mail: j.bahler@ucl.ac.uk
Interests: gene regulation; genomics; transcriptomics; next-generation sequencing; non-coding RNAs; genome evolution; fission yeast; oxidative stress response; cellular quiescence and ageing
Contribution:
In other journals:
Special Issue: Feature Papers
Dr. Nicolas Basse
UCB-Celltech, Department of Structural Biology, 216 Bath Road, Slough, SL1 4EN, UK
E-Mail: Nicolas.Basse@ucb.com
Interests: cancer; biophysics; structural biology; fragment based screening
Dr. Arturo López Castel
Valentia Biopharma, Parque Cientifico de la Universidad de Valencia (Vivero) C/ Catedrático José Beltrán, 2, 46980 Paterna, Valencia, Spain
Tel. +96 354 38 42
Website: http://www.valentiabiopharma.com
E-Mail: a.lopez@valentiabiopharma.com
Interests: rare disease; drug discovery; epigenetics; repeat instability; neuromuscular disease; splicing; DNA repair; DNA replication; transcription; animal models in drug discovery
Prof. Dr. Thomas Efferth
Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg, 555128 Mainz, Germany
Tel. +49 6131 3925751; Fax: +49 6131 3923752
E-Mail: efferth@uni-mainz.de
Interests: cancer; pharmacogenomics; molecular docking and virtual drug screening; molecular pharmacology; natural products; phytotherapy
Contribution:
In other journals:
Special Issue: Phytomedicine
Dr. Juan Pablo Fededa
Institute of Biochemistry, ETH Zürich, HPM D 11.1, Schafmattstrasse 18, 8050 Zürich, Switzerland
Tel. +41 44 633 91 71
Website: http://www.bc.biol.ethz.ch/people/groups/gerlichd/people/jfededa
E-Mail: jpfededa@bc.biol.ethz.ch
Interests: cell cycle regulation; high content screening; miRNA biology; alternative splicing
Prof. Dr. Ten Feizi
Department of Medicine, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK
Tel. +44 2075 947207
Website: http://www1.imperial.ac.uk/medicine/people/t.feizi/
E-Mail: t.feizi@imperial.ac.uk
Interests: oligosaccharide microarrays; carbohydrate microarrays
Prof. Dr. Jacqueline Franke
HTW Berlin, Life Science Engineering, Wilhelminenhofstr. 75A, 12459 Berlin, Germany
Tel. +49 30 5019 43 75
E-Mail: jacqueline.franke@htw-berlin.de
Interests: aging; intracellular transport; telomere function; compound screening; natural products; yeast genetics
Dr. Olivier Grenet
Investigative Toxicology - Genome biology Novartis Pharma AG, Werk Klybeck, Postfach CH-4002 Basel, Switzerland
Tel. +41 61 3241247; Fax: +41 61 3241027
Website: http://www.novartis.com
E-Mail: olivier.grenet@novartis.com
Interests: genomics; miRNA; next generation sequencing; Cynomolgus monkey; toxicology; safety assessment; non-human primates; epigenetic, biomarkers; diseases; PCR; drug development; arrays; evolutionary genetics; safety genetics; comparative biology; comparative toxicology
Prof. Dr. Andrey Grigoriev
Department of Biology, Center for Computational and Integrative Biology, Rutgers University Camden, NJ 08102, USA
Tel. +1 856 225 2960; Fax: +1 856 225 6312
E-Mail: agrigoriev@camden.rutgers.edu
Interests: genome and transcriptome organization; evolution; biological networks and pathways; translational medicine; cancer
Prof. Dr. Eggehard Holler
Department of Neurosurgery, Nanomedicine Research Center, Cedars Sinai Medical Center, 110 N. George Burns Rd., Davis 2100, Los Angeles, CA, 90048, USA
Tel. +1 310 423 6630; Fax: +1 310 423 0302
Website: http://www.cedars-sinai.edu/nsi
E-Mail: hollere@cshs.org
Interests: drug delivery on the nanoscale for cancer treatment; nanodrugs; nanomedicine; single molecule nanodrugs to deliver chemotherapeutica, antisense oligonucleotides, siRNA, MicroRNA,proteins and peptides; brain and breast tumors; breast and lung metastases of the brain; polymalic acid polyanion biodegradable nanoparticle; polyfunctional delivery vector; targeted drug delivery; blood-brain-barrier; membranolytic activity; transferrin receptor (antibody); nanodrug toxicity; nanoscale contrast reagent for magnetic resonance-imaging (MRI); MRI contrast enhancer reagent; Gd-DOTA; MRI of Alzheimer plaques; stem cells in brain tumor (Glioma multiforme); anti-tumor treatment brain and breast; triple-negative breast cancer; Her2-positive breast cancer; peptidomimetics; theranostic nanodevices
Dr. Oliver Kepp
INSERM (Institut national de la santé et de la récherche medicale), U848, Apoptosis, Cancer and Immunity, Institut Gustave Roussy, F-94805 Villejuif, France
Tel. +33 1 42 11 64 99
Website: http://www.kroemerlab.com
E-Mail: oliver.kepp@igr.fr
Interests: cancer, immunogenic cell death; drug repositioning, molecular pharmacology, host-tumor interactions
Dr. Tanja Kostic
Health & Environment Department, AIT Austrian Institute of Technology GmbH, Konrad Lorenz Strasse 24, A - 3430 Tulln an der Donau, Austria
Tel. +43 50550 3635; Fax: +43 50550 3666
E-Mail: tanja.kostic@ait.ac.at
Interests: microbial diagnostic microarrays (MDMs); detection of food- and water-borne pathogens; DNA-based microbial detection and typing
Dr. Mohammad Reza Lornejad-Schäfer
BioMed-zet Life Science GmbH, Industriezeile 36/I, 4020 Linz, Austria
Tel. +43 770325250; Fax: +43 770325213
E-Mail: lornejad@zet.or.at
Interests: physiology; nutrition; gastroenterology; hepatology; pharmacology; toxicology; nanotoxicology; cancer; aging, age-dependent macular degeneration; Alzheimer; signal transduction; oxidative stress; human three dimensional (3D) cell culture; stem cells; label free methods, alternative methods to animal testing
Prof. Dr. William Nierman
Infectious Diseases Program, J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850, USA
Tel. +1 301 795 7559
Website: http://www.jcvi.org/cms/about/bios/wnierman
E-Mail: wnierman@jcvi.org
Interests: infectious disease genomics; transcriptome analysis; host-pathogen interactions; respiratory system microbiome
Dr. Wayne F. Patton
Enzo Life Sciences, 10 Executive Blvd, Farmingdale, NY 11735, USA
Tel. +1 631 694 7070
E-Mail: wpatton@enzolifesciences.com
Interests: fluorescence; molecular probes; RNA amplification; array CGH; phosphorylation; reverse arrays; proteomics; genomics
Dr. Konrad Sachse
Friedrich-Loeffler-Institut (Federal Research Institute for Animal Health), Institute of Molecular Pathogenesis, OIE Reference Laboratory for Chlamydiosis, Naumburger Str. 96a, 07743 Jena, Germany
Tel. +49 3641 804 2334; Fax: +49 3641 804 2228
Website: http://www.fli.bund.de
E-Mail: konrad.sachse@fli.bund.de
Interests: chlamydia infections; zoonotic transmission; mycoplasma infections; molecular pathogenesis; rapid diagnostic tests; real-time PCR; DNA microarrays
Prof. Dr. Reinhold Schäfer
Laboratories of Molecular Tumor Pathology and of Functional Genomics, Charité - Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany
Tel. +49 30 450 536 072; Fax: +49 30 450 536 909
Website: http://mtp.charite.de
E-Mail: reinhold.schaefer@charite.de
Interests: cancer-specific alterations of the genetic program in mesenchymal and epithelial cells analyzed by expression profiling; identification and functional characterization of transcriptional targets responding to signaling pathways downstream of the RAS oncoprotein; understanding RAS-mediated signal transduction at the systems level
Dr. Josef Scheiber
Pharma Research & Early Development Informatics - Disease & Translational Informatics Pharma Research and Early Development (pRED), Roche Diagnostics GmbH, Biomedical Informatics, Nonnenwald 2, 82377 Penzberg, Germany
Tel. +49 8856 60 3856
E-Mail: josef.scheiber@roche.com
Interests: bioinformatics; oncology; systems biology; personal genomics; pharmacogenomics; pharmacology; translational medicine
Dr. Veronica Soloveva
IP-Korea, Center for Core Technologies, 696 Sampyeong-dong, Bundang-gu, Seongnam-si, 463-400, South Korea
Tel. +8231 8018 8008
E-Mail: Soloveva@IP-korea.org
Interests: HCS; target free; siRNA microarrays; shRNA Lentivirus; cDNA microarrays; cellular assays; phenotypic assays; HTS; GPCR; cellular pathway; differentiation; primary cells; stem cells; automation; screening platforms
Dr. Maria Wendt
Genedata AG, Margarethenstrasse 38, CH 4053 Basel, Switzerland
Tel. +41 61 511 8415
E-Mail: maria.wendt@genedata.com
Interests: large-scale -omics data management; microarray and deep-sequencing applications for biologics R&D, incl. antibody discovery, cell line engineering, and bioprocess optimization
Mr. Neil Winegarden
Toronto Medical Discovery Tower, 101 College Street, TMDT Rm 9-312, Toronto, ON, M5G 1L7, Canada
Website: http://www.microarrays.ca
E-Mail: winegard@uhnresearch.ca
Interests: cancer; in vitro fertilization; single cell analysis; transcriptomics; epigenomics; DNA arrays; RNA arrays; protein arrays; cell arrays
|
